Mini Review
Volume 8 Issue 11 - 2021
Obesity, Overweight, and the Microbiome
Álvaro Zamudio Tiburcio1*, Nydia Ávila Vanzzini2, Silverio Alonso López3 and María Magdalena Aguirre-García4
1Gastroenterologist, Intestinal Microbiota Transplantation, Pennsylvania, Naples Neighborhood, ZIP City Hall Benito Juárez, (Medical Specialties Naples), Mexico City, Mexico
2Physician of the Department of Outpatient Care, National Institute of Cardiology Ignacio Chávez, Mexico City, Mexico
33Urologist, Chairman Medical Specialties, Naples neighborhood, Mexico City, Mexico
4Unidad de Investigación UNAM-INC, División de Investigación, Facultad deMedicina, Instituto Nacional de Cardiología Ignacio Chávez, Ciudad de México, México
*Corresponding Author: Álvaro Zamudio Tiburcio, Gastroenterologist, Intestinal Microbiota Transplantation, Pennsylvania, Naples neighborhood, ZIP City Hall Benito Juárez, (Medical Specialties Naples), Mexico City, Mexico.
Received: September 01, 2021; Published: October 18, 2021


Overweight and obesity, among the most common diseases in the world, contribute to other pathological conditions including cardiovascular disease, cancer, and metabolic syndrome. Excess corporal fat results from an imbalance between energy intake and expenditure, which involves diet and exercise as well as the possible participation of genetics and environmental factors. Overweight and obesity produce changes in the gut microbiota because of altering intestinal permeability (endo-toxemia), stimulating the endocannabinoid system, and increasing the provision of calories. All these alterations must be considered in a treatment strategy to return a patient to homeostasis. The aim of the present study was to analyze the gut microbiota in relation to overweight and obesity in order to explore strategies to reduce excess fat by restoring microbiota homeostasis. Such strategies have the potential not only of improving the health of individuals, but also of enabling enormous savings in the health care system.

Keywords: Obesity; Overweight; Microbiome; Intestinal Microbiota; Fecal Microbiota Transplantation; Intestinal Microbiota Transplantation


  1. Dávila-Torres J., et al. “Obesity in Mexico”. Revista Médica del Instituto Mexicano del Seguro Social2 (2015).
  2. Davis CD. “The Gut Microbiome and Its Role in Obesity”. Nutrition Today4 (2016): 167-174.
  3. Pothiwuala P., et al. “Metabolic Syndrome and cancer”. Metabolic Syndrome and Related Disorders4 (2009): 279-287.
  4. Poirier P., et al. “Obesity and Cardiovascular Disease: Pathophysiology, Evaluation, and Effect of Weight Loss”. Circulation Volume6 (2006): 898-918.
  5. Castaner O., et al. “The Gut Microbiome Profile in Obesity: A Systematic Review”. International Journal of Endocrinology (2018): 4095789.
  6. Sivamaruthi BS., et al. “A Review on Role of Microbiome in Obesity and Antiobesity Properties of Probiotic Supplements”. BioMed Research International Volume (2019): 20.
  7. World Health Organization. Obesity and overweight (2020).
  8. Molina Montes E. “Microbioma, microbiota y cancer”. Febrero. SEBBM (2018).
  9. Gilbert J., et al. “Current Understanding of the human microbiome”. Nature Medicine4 (2018): 392-400.
  10. Mohajeri MH., et al. “The role of the microbiome for human health: from basic science to Clinical applications”. European Journal of Nutrition1 (2018): 1-14.
  11. Heintz- Buschart A and Wilmes P. “Human Gut Microbiome; Function Matters”. Trends in Microbiology7 (2017): 563-574.
  12. Valdes AM., et al. “Role of the gut microbiota in Nutrition and health”. British Medical Journal 361 (2018): k2179.
  13. Yu EW., et al. “Fecal microbiota transplantation for the improvement of metabolism in Obesity: The FMT-TRIM double-blind placebo-controlled pilot trial”. PLOS Medicine3 (2020): e1003051.
  14. Akter D., et al. “Potential Health-Promoting Benefits of Para-probiotics, Inactivated Probiotic Cells”. Journal of Microbiology and Biotechnology4 (2020): 477-481.
  15. Clemente JC., et al. “The Impact of the Gut Microbiota on Human Health: An Integrative View”. Cell6 (2012): 1258-1270.
  16. Guinane CM and Cotter D. “Role of the gut microbiota in health and chronic Gastrointestinal disease: understanding a hidden metabolic organ”. Therapeutic Advances in Gastroenterology4 (2013): 295-308.
  17. Thursby E and Juge N. “Introduction to the human gut microbiota”. Biochemical Journal11 (2017): 1823-1836.
  18. Pickard JM., et al. “Gut Microbiota: Role in Pathogen Colonization, Immune Responses and Inflammatory Disease”. Immunological Reviews1 (2017): 70-89.
  19. King CH., et al. “Baseline human gut microbiota profile in healthy people and standard Reporting template”. PLOS ONE (2019).
  20. Ferranti E., et al. “20 Things you Didn’t Know About the Human gut Microbiome”. Journal of Cardiovascular Nursing6 (2014): 479-481.
  21. Belkaid Y and Harrison OJ. “Homeostatic immunity and the microbiota”. Immunity4 (2017): 562-576.
  22. Rinninella E., et al. “What is the Healthy Gut Microbiota Composition? A Changing Ecosystem across Age, Environment, Diet, and Diseases”. Microorganisms1 (2019): 14.
  23. Bull MJ and Plummer NT. “Part 1: The Human Gut Microbiome in Health and Disease”. Journal of Integrative Medicine6 (2014): 17-22.
  24. Phillips ML. “Gut Reaction: Environmental Effects on the Human Microbiota”. Environmental Health Perspectives5 (2009): A198-A205.
  25. Almeida A., et al. “A Unified catalog of 204,938 reference genomes from the human gut Microbiome”. Nature Biotechnology (2020).
  26. Li J., et al. “An integrated catalog of reference genes in the human Gut microbiome”. Nature Biotechnology Volume 32 (2014): 834-841.
  27. Dudek-Wicher RK., et al. “The influence of antibiotics And dietary components on gut microbiota”. Przeglad Gastroenterologiczny13.2 (2018): 85-92.
  28. Walker RW., et al. “The prenatal gut microbiome: Are we colonized with bacteria in utero?” Pediatric Obesity1 (2017): 3-17.
  29. Rodríguez JM., et al. “The Composition of the gut microbiota throughout life, with an emphasis on Early life”. Microbial Ecology in Health and Disease (2015).
  30. Grigorescu I and Dumitrascu DL. “Implication Of Gut Microbiota In Diabetes Mellitus And Obesity”. Acta Endocrinologica2 (2016): 206-214.
  31. Angekalis E., et al. “A Metagenomic Investigation of the Duodenal Microbiota Reveals Links With Obesity”. PLOS ONE (2015).
  32. Cani PD., et al. “Involvement of gut microbiota in the Development of low-grade inflammation and type 2 diabetes associated With obesity”. Gut Microbes4 (2012): 279-288.
  33. Geldenhuys WJ., et al. “Emerging strategies of Targeting lipoprotein lipase for metabolic and cardiovascular diseases”. Drug Discovery Today2 (2017): 352-365.
  34. Kasai C., et al. “Comparison of the gut microbiota composition between obese and non- Obese individuals in a Japanese population, as analyzed by terminal Restriction fragment length polymorphism and next-generation sequencing”. BMC Gastroenterology 15 (2015): 100.
  35. Turnbaugh PJ. “Microbes and diet-induced obesity: fast, cheap, and out of Control”. Cell Host and Microbe3 (2017): 278-281.
  36. Gray A and Threlkeld RJ. “Nutritional Recommendations for Individuals with Diabetes”. Endotext (2019).
  37. Paoli A., et al. “Ketogenic Die And Microbiota: Friends or Enemies?” Genes7 (2019): 534.
  38. Wegh AM., et al. “Postbiotics and Their Potential Applications in Early Life Nutrition and Beyond”. International Journal of Molecular Sciences19 (2019): 4673.
  39. Kobyliak N., et al. “Probiotics in prevention and treatment of obesity: a critical view”. Nutrition and Metabolism Volume14 (2016).
  40. Lin DM., et al. “Phage therapy: An alternative to antibiotics in The age of multi-drug resistance”. World Journal of Gastrointestinal Pharmacology and Therapeutics3 (2017): 162-173.
  41. Petersen C and Round JL. “Defining dysbiosis and its influence on host Immunity and disease”. Cell Microbiology7 (2014): 1024-1033.
  42. Carding S., et al. “Dysbiosis of the gut Microbiota in disease”. Microbial Ecology in Health and Disease (2015).
  43. S. Food and Drugs Administration. Fecal Microbiota for Transplantation: New Safety Information - Regarding Additional Protections for Screening Donors for COVID-19 and Exposure toSARS-CoV-2 and Testing for SARS-CoV-2 (2020).
Citation: Álvaro Zamudio Tiburcio., et al. “Obesity, Overweight, and the Microbiome”. EC Gastroenterology and Digestive System 8.11 (2021): 20-26.

PubMed Indexed Article

EC Pharmacology and Toxicology
LC-UV-MS and MS/MS Characterize Glutathione Reactivity with Different Isomers (2,2' and 2,4' vs. 4,4') of Methylene Diphenyl-Diisocyanate.

PMID: 31143884 [PubMed]

PMCID: PMC6536005

EC Pharmacology and Toxicology
Alzheimer's Pathogenesis, Metal-Mediated Redox Stress, and Potential Nanotheranostics.

PMID: 31565701 [PubMed]

PMCID: PMC6764777

EC Neurology
Differences in Rate of Cognitive Decline and Caregiver Burden between Alzheimer's Disease and Vascular Dementia: a Retrospective Study.

PMID: 27747317 [PubMed]

PMCID: PMC5065347

EC Pharmacology and Toxicology
Will Blockchain Technology Transform Healthcare and Biomedical Sciences?

PMID: 31460519 [PubMed]

PMCID: PMC6711478

EC Pharmacology and Toxicology
Is it a Prime Time for AI-powered Virtual Drug Screening?

PMID: 30215059 [PubMed]

PMCID: PMC6133253

EC Psychology and Psychiatry
Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse.

PMID: 30417173 [PubMed]

PMCID: PMC6226033

EC Anaesthesia
Arrest Under Anesthesia - What was the Culprit? A Case Report.

PMID: 30264037 [PubMed]

PMCID: PMC6155992

EC Orthopaedics
Distraction Implantation. A New Technique in Total Joint Arthroplasty and Direct Skeletal Attachment.

PMID: 30198026 [PubMed]

PMCID: PMC6124505

EC Pulmonology and Respiratory Medicine
Prevalence and factors associated with self-reported chronic obstructive pulmonary disease among adults aged 40-79: the National Health and Nutrition Examination Survey (NHANES) 2007-2012.

PMID: 30294723 [PubMed]

PMCID: PMC6169793

EC Dental Science
Important Dental Fiber-Reinforced Composite Molding Compound Breakthroughs

PMID: 29285526 [PubMed]

PMCID: PMC5743211

EC Microbiology
Prevalence of Intestinal Parasites Among HIV Infected and HIV Uninfected Patients Treated at the 1o De Maio Health Centre in Maputo, Mozambique

PMID: 29911204 [PubMed]

PMCID: PMC5999047

EC Microbiology
Macrophages and the Viral Dissemination Super Highway

PMID: 26949751 [PubMed]

PMCID: PMC4774560

EC Microbiology
The Microbiome, Antibiotics, and Health of the Pediatric Population.

PMID: 27390782 [PubMed]

PMCID: PMC4933318

EC Microbiology
Reactive Oxygen Species in HIV Infection

PMID: 28580453 [PubMed]

PMCID: PMC5450819

EC Microbiology
A Review of the CD4 T Cell Contribution to Lung Infection, Inflammation and Repair with a Focus on Wheeze and Asthma in the Pediatric Population

PMID: 26280024 [PubMed]

PMCID: PMC4533840

EC Neurology
Identifying Key Symptoms Differentiating Myalgic Encephalomyelitis and Chronic Fatigue Syndrome from Multiple Sclerosis

PMID: 28066845 [PubMed]

PMCID: PMC5214344

EC Pharmacology and Toxicology
Paradigm Shift is the Normal State of Pharmacology

PMID: 28936490 [PubMed]

PMCID: PMC5604476

EC Neurology
Examining those Meeting IOM Criteria Versus IOM Plus Fibromyalgia

PMID: 28713879 [PubMed]

PMCID: PMC5510658

EC Neurology
Unilateral Frontosphenoid Craniosynostosis: Case Report and a Review of the Literature

PMID: 28133641 [PubMed]

PMCID: PMC5267489

EC Ophthalmology
OCT-Angiography for Non-Invasive Monitoring of Neuronal and Vascular Structure in Mouse Retina: Implication for Characterization of Retinal Neurovascular Coupling

PMID: 29333536 [PubMed]

PMCID: PMC5766278

EC Neurology
Longer Duration of Downslope Treadmill Walking Induces Depression of H-Reflexes Measured during Standing and Walking.

PMID: 31032493 [PubMed]

PMCID: PMC6483108

EC Microbiology
Onchocerciasis in Mozambique: An Unknown Condition for Health Professionals.

PMID: 30957099 [PubMed]

PMCID: PMC6448571

EC Nutrition
Food Insecurity among Households with and without Podoconiosis in East and West Gojjam, Ethiopia.

PMID: 30101228 [PubMed]

PMCID: PMC6086333

EC Ophthalmology
REVIEW. +2 to +3 D. Reading Glasses to Prevent Myopia.

PMID: 31080964 [PubMed]

PMCID: PMC6508883

EC Gynaecology
Biomechanical Mapping of the Female Pelvic Floor: Uterine Prolapse Versus Normal Conditions.

PMID: 31093608 [PubMed]

PMCID: PMC6513001

EC Dental Science
Fiber-Reinforced Composites: A Breakthrough in Practical Clinical Applications with Advanced Wear Resistance for Dental Materials.

PMID: 31552397 [PubMed]

PMCID: PMC6758937

EC Microbiology
Neurocysticercosis in Child Bearing Women: An Overlooked Condition in Mozambique and a Potentially Missed Diagnosis in Women Presenting with Eclampsia.

PMID: 31681909 [PubMed]

PMCID: PMC6824723

EC Microbiology
Molecular Detection of Leptospira spp. in Rodents Trapped in the Mozambique Island City, Nampula Province, Mozambique.

PMID: 31681910 [PubMed]

PMCID: PMC6824726

EC Neurology
Endoplasmic Reticulum-Mitochondrial Cross-Talk in Neurodegenerative and Eye Diseases.

PMID: 31528859 [PubMed]

PMCID: PMC6746603

EC Psychology and Psychiatry
Can Chronic Consumption of Caffeine by Increasing D2/D3 Receptors Offer Benefit to Carriers of the DRD2 A1 Allele in Cocaine Abuse?

PMID: 31276119 [PubMed]

PMCID: PMC6604646

EC Anaesthesia
Real Time Locating Systems and sustainability of Perioperative Efficiency of Anesthesiologists.

PMID: 31406965 [PubMed]

PMCID: PMC6690616

EC Pharmacology and Toxicology
A Pilot STEM Curriculum Designed to Teach High School Students Concepts in Biochemical Engineering and Pharmacology.

PMID: 31517314 [PubMed]

PMCID: PMC6741290

EC Pharmacology and Toxicology
Toxic Mechanisms Underlying Motor Activity Changes Induced by a Mixture of Lead, Arsenic and Manganese.

PMID: 31633124 [PubMed]

PMCID: PMC6800226

EC Neurology
Research Volunteers' Attitudes Toward Chronic Fatigue Syndrome and Myalgic Encephalomyelitis.

PMID: 29662969 [PubMed]

PMCID: PMC5898812

EC Pharmacology and Toxicology
Hyperbaric Oxygen Therapy for Alzheimer's Disease.

PMID: 30215058 [PubMed]

PMCID: PMC6133268

News and Events

November Issue Release

We always feel pleasure to share our updates with you all. Here, notifying you that we have successfully released the November issue of respective journals and the latest articles can be viewed on the current issue pages.

Submission Deadline for Upcoming Issue

ECronicon delightfully welcomes all the authors around the globe for effective collaboration with an article submission for the upcoming issue of respective journals. Submissions are accepted on/before December 09, 2022.

Certificate of Publication

ECronicon honors with a "Publication Certificate" to the corresponding author by including the names of co-authors as a token of appreciation for publishing the work with our respective journals.

Best Article of the Issue

Editors of respective journals will always be very much interested in electing one Best Article after each issue release. The authors of the selected article will be honored with a "Best Article of the Issue" certificate.

Certifying for Review

ECronicon certifies the Editors for their first review done towards the assigned article of the respective journals.

Latest Articles

The latest articles will be updated immediately on the articles in press page of the respective journals.